CUTRIGNELLI, ANNALISA
 Distribuzione geografica
Continente #
NA - Nord America 7.556
AS - Asia 3.230
EU - Europa 3.195
SA - Sud America 799
Continente sconosciuto - Info sul continente non disponibili 341
AF - Africa 116
OC - Oceania 12
Totale 15.249
Nazione #
US - Stati Uniti d'America 7.392
SG - Singapore 1.263
IT - Italia 1.169
CN - Cina 797
BR - Brasile 628
SE - Svezia 455
HK - Hong Kong 387
RU - Federazione Russa 311
FI - Finlandia 286
DE - Germania 251
VN - Vietnam 194
FR - Francia 182
GB - Regno Unito 172
UA - Ucraina 143
IN - India 109
BD - Bangladesh 108
CA - Canada 77
AR - Argentina 59
ID - Indonesia 54
IQ - Iraq 51
JP - Giappone 51
MX - Messico 44
TR - Turchia 41
ZA - Sudafrica 34
CI - Costa d'Avorio 33
PK - Pakistan 32
NL - Olanda 30
EC - Ecuador 29
ES - Italia 29
AT - Austria 27
VE - Venezuela 26
BE - Belgio 25
CO - Colombia 23
IE - Irlanda 22
PL - Polonia 21
CZ - Repubblica Ceca 16
SA - Arabia Saudita 16
MA - Marocco 15
LT - Lituania 13
MY - Malesia 13
AU - Australia 12
UZ - Uzbekistan 12
KR - Corea 11
PH - Filippine 11
PY - Paraguay 10
AZ - Azerbaigian 9
CL - Cile 9
IR - Iran 8
JM - Giamaica 8
JO - Giordania 8
TH - Thailandia 8
CH - Svizzera 7
EG - Egitto 7
ET - Etiopia 7
AE - Emirati Arabi Uniti 6
BH - Bahrain 6
CR - Costa Rica 6
KZ - Kazakistan 6
NI - Nicaragua 6
PT - Portogallo 6
RO - Romania 6
UY - Uruguay 6
NP - Nepal 5
PE - Perù 5
BO - Bolivia 4
BY - Bielorussia 4
HN - Honduras 4
KE - Kenya 4
AM - Armenia 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AL - Albania 2
BB - Barbados 2
EE - Estonia 2
GE - Georgia 2
HR - Croazia 2
KW - Kuwait 2
MD - Moldavia 2
MG - Madagascar 2
MK - Macedonia 2
MR - Mauritania 2
MU - Mauritius 2
NG - Nigeria 2
QA - Qatar 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CG - Congo 1
CU - Cuba 1
DZ - Algeria 1
EU - Europa 1
GD - Grenada 1
GP - Guadalupe 1
Totale 14.888
Città #
Ashburn 768
Singapore 691
Fairfield 650
Chandler 524
Woodbridge 437
San Jose 434
Hong Kong 386
Houston 376
Nyköping 341
Jacksonville 328
Seattle 298
Cambridge 284
Milan 284
Beijing 258
Wilmington 222
Ann Arbor 209
Helsinki 195
New York 195
Bari 177
Council Bluffs 156
Dallas 129
Los Angeles 124
Lawrence 109
Roxbury 106
Lauterbourg 97
Nanjing 92
Boardman 81
Rome 80
Santa Clara 70
Brooklyn 68
Des Moines 68
Ho Chi Minh City 64
Princeton 62
São Paulo 53
Bitonto 50
Hanoi 45
Chicago 44
Grottaglie 44
Buffalo 42
Munich 41
Bitetto 40
Jakarta 40
London 34
Abidjan 33
Columbus 33
Shenyang 32
Napoli 31
San Diego 31
Inglewood 30
Frankfurt am Main 29
Tokyo 27
Brussels 25
Jiaxing 23
Tianjin 23
Baghdad 22
Dublin 22
Falkenstein 22
Figino 22
Hebei 22
Johannesburg 22
Orem 22
Nanchang 21
Montreal 20
San Francisco 20
Toronto 20
Denver 19
Paris 19
Turin 19
Amsterdam 18
Vienna 18
Warsaw 18
Washington 18
Phoenix 17
Turku 17
Atlanta 16
Changsha 16
Moscow 16
Nuremberg 16
Guangzhou 15
Mexico City 15
Rio de Janeiro 15
Belo Horizonte 14
Chennai 14
Dong Ket 14
Guayaquil 14
Porto Alegre 14
Shanghai 14
Stockholm 14
The Dalles 14
North Bergen 13
Campinas 12
Toranomon 12
Wuhan 12
Elk Grove Village 11
Manchester 11
Poplar 11
Boston 10
Mumbai 10
Naples 10
Quito 10
Totale 9.854
Nome #
S-preactivated thiolated glycol chitosan useful to combine mucoadhesion and drug delivery 320
Proof-of-concept validation of the mechanism of action of Src tyrosine kinase inhibitors in dystrophic mdx mouse muscle: in vivo and in vitro studies 297
Spray-dried mucoadhesives for intravesical drug delivery using N-acetylcysteine- and glutathione-glycol chitosan conjugates 255
Preactivated thiolated glycogen as mucoadhesive polymer for drug delivery 248
Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat 247
2-Phenylimidazo[1,2-a]pyridine-containing ligands of the 18-kDa translocator protein (TSPO) behave as agonists and antagonists of steroidogenesis in a mouse leydig tumor cell line. 222
Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat 219
Dasatinib/HP-β-CD inclusion complex based aqueous formulation as a promising tool for the treatment of paediatric neuromuscular disorders 214
A new complex of curcumin with sulfobutylether-β-cyclodextrin: characterization studies and in vitro evaluation of cytotoxic and antioxidant activity on HepG-2 cells 205
Taste masking of propranolol hydrochloride by microbeads of EUDRAGIT® E PO obtained with prilling technique for paediatric oral administration 199
Sorafenib delivery nanoplatform based on superparamagnetic iron oxide nanoparticles magnetically targets hepatocellular carcinoma 198
Bridging Pharmaceutical Chemistry with Drug and Nanoparticle Targeting to Investigate the Role of the 18-kDa Translocator Protein TSPO. 195
Drug delivery nanovectors based on SPIONS for targeted therapy of hepatocellular carcinoma 193
A Novel PET Imaging Probe for the Detection and Monitoring of Translocator Protein 18 kDa Expression in Pathological Disorders 192
Delivery of proapoptotic agents in glioma cell lines by TSPO ligand–dextran nanogels 191
A histochemical approach to glycan diversity in the urothelium of pig urinary bladder 189
Bcr-abl tyrosine kinase inhibitors in the treatment of pediatric cml 187
Alginate-Based Hydrogel Containing Minoxidil/Hydroxypropyl-β-Cyclodextrin Inclusion Complex for Topical Alopecia Treatment 185
Oxazepam-Dopamine Conjugates Increase Dopamine Delivery into Striatum of Intact Rats 183
Spray Dried Chitosan Microparticles for Intravesical Delivery of Celecoxib: Preparation and Characterization. 175
TSPO ligand-methotrexate prodrug conjugates: Design, synthesis, and biological evaluation 171
Encapsulation of lipophilic kiteplatin Pt(IV) prodrugs in PLGA-PEG micelles 171
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 169
Imaging modification of colon carcinoma cells exposed to lipid based nanovectors for drug delivery: a scanning electron microscopy investigation 168
Effect of cyclodextrins on physico-chemical and release properties of Eudragit RS 100 microparticles containing glutathione 162
b-Cyclodextrin in personal care formulation: role on the complexation of malodors causing molecules 158
Pharmaceutical preformulation studies and paediatric oral formulations of sodium dichloroacetate 158
Targeting human liver cancer cells with lactobionic acid-G(4)-PAMAM-FITC sorafenib loaded dendrimers 158
The hydroxypropyl‐β‐cyclodextrin‐minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia 155
Spray-dried mucoadhesive microparticles based on S-protected thiolated hydroxypropyl-β-cyclodextrin for budesonide nasal delivery 151
Colonic budesonide delivery by multistimuli alginate/Eudragit® FS 30D/inulin-based microspheres as a paediatric formulation 150
Transferrin Functionalized Liposomes Loading Dopamine HCl: Development and Permeability Studies across an In Vitro Model of Human Blood-Brain Barrier 147
Characterization and release studies of liposomal gels containing glutathione/cyclodextrins complexes potentially useful for cutaneous administration 147
Single-dose extended-toxicity preclinical study on novel radiotracer formulations for use in the diagnosis of neuroendocrine tumor and neurodegenerative disorders 143
B-CYCLODEXTRIN IN PERSONAL CARE FORMULATION: ROLE ON THE COMPLEXATION OF MALODORS CAUSING MOLECULES 142
Comparative effect of some hydrophilic excipients on the rate of gabapentin and baclofen lactamization in lyophilized formulations 137
Translocator Protein Ligand-PLGA conjugates nanoparticles for 5-Fluorouracil Delivery to Glioma Cancer Cells 137
Pharmaceutical development of novel lactate-based 6-fluoro-L-DOPA formulations 135
Chitosan/sulfobutylether-β-cyclodextrin based nanoparticles coated with thiolated hyaluronic acid for indomethacin ophthalmic delivery 134
Hydroxy-propil-β-cyclodextrin inclusion complexes of two biphenylnicotinamide derivatives: Formulation and anti-proliferative activity evaluation in pancreatic cancer cell models 133
In vitro targeting and imaging the translocator protein TSPO 18-kDa through G(4)-PAMAM-FITC labeled dendrimer 131
From oil to microparticulate by prilling technique: Production of polynucleate alginate beads loading Serenoa Repens oil as intestinal delivery systems 129
beta-Cyclodextrin in personal care formulation: role on the complexation of malodours causing molecules 128
Chitosan- And Glycolchitosan-Based Nanoparticles For Methotrexate Administration Across The Blood Brain Barrier 127
Nanoparticelle a base di Eudragit® RS 100 contenenti ciclodestrine utili per la somministrazione transmucosale di Glutatione 127
β‐Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation 124
Synthesis, characterization, and in vitro evaluation of a new TSPO-selective bifunctional chelate ligand 123
Natural dendrimers: Synthesis and in vitro characterization of glycogen-cysteamine conjugates 123
PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study 123
Comparative effects of some hydrophilic excipients on the rate of gabapentin and baclofen lactamization in lyophilized formulations 122
Magnetic implants in vivo guiding sorafenib liver delivery by superparamagnetic solid lipid nanoparticles 122
Griseofulvin/carrier blends: application of partial least squares (PLS) regression analysis for estimating the factors affecting the dissolution efficiency. 120
Direct cyclodextrin-based powder extrusion 3D printing for one-step production of the BCS class II model drug niclosamide 120
Design and synthesis of grafted TSPO ligand-amino functionalized silica-coated quantum dots 119
Thiolated hydroxypropyl-β-cyclodextrin as mucoadhesive excipient for oral delivery of budesonide in liquid paediatric formulation 119
Chitosan- And Glycolchitosan-Based Nanoparticles For Methotrexate Administration Across The Blood Brain Barrier 118
β-cyclodextrin in personal care formulations: role on the complexation of malodours causing molecules 118
Comparative study of gels containing a minoxidil/MebCD complex with conventional formulation 116
Complexation of phenytoin with some hydrophilic cyclodextrins: effect on aqueous solubility, dissolution rate, and anticonvulsant activity in mice 116
Combined Eudragit RS100 cyclodextrin nanoparticles intended for transmucosal administration of Glutathione 116
Induced expression of P-gp and BCRP transporters on brain endothelial cells using transferrin functionalized nanostructured lipid carriers: A first step of a potential strategy for the treatment of Alzheimer's disease 116
New ethanol and propylene glycol free gel formulations containing a minoxidil-methyl-β-cyclodextrin complex as promising tools for alopecia treatment 113
The use of Eudragit RS100/cyclodextrin nanoparticles for the transmucosal administration of glutathione 112
Stability data of extemporaneous suspensions of hydroxychloroquine sulphate in oral liquid bases after tablet manipulation 110
DEVELOPMENT OF MUCOADHESIVE MICROSPHERES AS CELECOXIB DELIVERY SYSTEMS IN THE BLADDER 109
COLD KITS BASED ON PSMA LIGANDS FOR THE PREPARATION OF RADIOPHARMACEUTICALS 108
Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies 107
New nanostructured self-assemblong inulin-a-tocopherol bioconjugates for biomedical applications 107
Frog intestinal sac as an in vitro method for the assessment of intestinal permeability in humans: Application to carrier transported drugs 107
Reproducibility warning: The curious case of polyethylene glycol 6000 and spheroid cell culture 107
COMPARATIVE STUDY OF GELS CONTAINING A MINOXIDIL/MEbCD COMPLEX WITH CONVENTIONAL FORMULATIONS 106
Investigating the prilling/vibration technique to produce gastric-directed drug delivery systems for misoprostol 104
In vitro targeting and imaging the translocator protein TSPO 18-kDa through G(4)-PAMAM–FITC labeled dendrimer 104
Griseofulvin/carrier blends: identification of factors affecting the dissolution efficiency of solid dispersions using carrier molecular descriptors and Partial Least-Squares (PLS) regression analysis 103
Development of purified glycogen derivatives as siRNA nanovectors 103
Microfluidic preparation and in vitro evaluation of iRGD-functionalized solid lipid nanoparticles for targeted delivery of paclitaxel to tumor cells 102
Solid lipid nanoparticles as a novel delivery system for the antioxidant glutathione 101
Preparation of cetyl palmitate-based PEGylated solid lipid nanoparticles by microfluidic technique 101
Valproic acid hydrophilic cyclodextrin complexes and valproic acid-solid 98
Morphology loading and release properties of poly(D,L-lactide-co-glycolide) microparticles containing the hypnotic agent etizolam 98
Relationship between dissolution efficiency of Oxazepam/carrier blends and drug and carrier molecular descriptors using multivariate regression analysis 97
Microfluidic development and biological evaluation of targeted therapy-loaded biomimetic nano system to improve the metastatic melanoma treatment 96
NEW BIODEGRADABLE HYDROGELS DESIGNED FOR COLONIC DRUG DELIVERY: IN VITRO RELEASE OF THE PEPTIDES GLUTATHIONE AND OXYTOCIN 96
SPRAY DRIED MICROPARTICLES OF CHITOSAN OR ITS THIOLIC DERIVATES FOR CELECOXIB INTRAVESCICAL DELIVERY 96
Effect of cyclodextrins on physico-chemical and release properties of Eudragit RS 100 microparticles containing Glutathione 96
SYNTHESIS, CHARACTERIZATION AND CELLULAR INTERNALIZATION OF TSPO TARGETED G(4)-PAMAM DENDRIMERS INTO C6 RAT GLIOMA CELLS. 95
Effectiveness of a controlled 5-fu delivery based on fzd10 antibody-conjugated liposomes in colorectal cancer in vitro models 95
Radiosynthesis and characterization of [18F]BS224: a next-generation TSPO PET ligand insensitive to the rs6971 polymorphism 95
NEW ETHANOL-FREE FORMULATIONS CONTAINING A MINOXIDIL/METHYL-b-CICLODEXTRIN COMPLEX IN ALOPECIA TREATMENT 94
Complexation of phenytoin with some hydrophilic ciclodextrins: effect on aqueous solubilità, dissolution rate, and anticonvulsant activity in mice 94
Highly selective luminescent nanostructures for mitochondrial imaging and targeting 93
null 92
SPRAY DRIED MICROPARTICLES OF CHITOSAN OR ITS THIOLIC DERIVATES FOR CELECOXIB INTRAVESCICAL DELIVERY 89
Mucoadhesive Budesonide Solution for the Treatment of Pediatric Eosinophilic Esophagitis 88
Comparative study among some potential dermal formulations intended for glutathione administration 88
Effects of different cyclodextrins on the morphology, loading and release properties of poly(DL-lactide-co-glycolide)-microparticles containing the hypnotic agent etizolam. 88
NEW NANOSTRUCTURED SELF-ASSEMBLING INULIN-α-TOCOPHEROL BIOCONJUGATES FOR BIOMEDICAL APPLICATION 87
SYNTHESIS, CHARACTERIZATION AND CELLULAR INTERNALIZATION OF GRAFTED TSPO LIGAND-AMINO FUNCTIONALIZED SILICA-COATED QUANTUM DOTS INTO C6 RAT GLIOMA CELLS 86
Valproic acid-hydrophilic cyclodextrin complexes and valproic acid-solid dispersions: evaluation of their potential pharmaceutical use 85
Preparation and characterization of gels containing a minoxidil /MebCD complex for cutaneous delivery in alopecia 83
Totale 13.730
Categoria #
all - tutte 61.947
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.947


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022807 0 0 7 19 35 85 48 35 80 123 140 235
2022/20231.474 217 193 107 124 162 190 29 160 215 21 39 17
2023/2024711 36 107 40 40 79 201 59 53 10 13 20 53
2024/20252.468 95 47 197 87 103 223 326 223 61 111 345 650
2025/20265.100 723 244 354 522 505 275 576 185 563 464 174 515
2026/2027533 150 202 181 0 0 0 0 0 0 0 0 0
Totale 15.249